Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma
Byung Ju Kang, Seung Won Ra, Kyusang Lee, Soyeoun Lim, So Hee Son, Jong-Joon Ahn, Byung Chul Kim
Tuberc Respir Dis. 2020;83(1):61-70.   Published online 2019 Dec 24     DOI:
Citations to this article as recorded by Crossref logo
Biomarkers and diagnostic tools for lung cancer
Sang Hoon Lee, Eun Hye Lee, Eun Young Kim, Yong Jun Choi, Yoon Jin Cha, Yoon Soo Chang
Journal of the Korean Medical Association.2021; 64(1): 66.     CrossRef
Recent advances in diagnostic technologies in lung cancer
Hye Jung Park, Sang Hoon Lee, Yoon Soo Chang
The Korean Journal of Internal Medicine.2020; 35(2): 257.     CrossRef

Clinical Significance of Red Cell Distribution Width and Circulating Tumor Cells with an Epithelial–Mesenchymal Transition Phenotype in Lung Adenocarcinoma

Huajian Peng, Xiang Tan, Yongyong Wang, Lei Dai, Guanbiao Liang, Jianji Guo, Mingwu Chen
Cancer Management and Research.2020; Volume 12: 5105.     CrossRef
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Stephan Klöß, Susann Dehmel, Armin Braun, Michael J. Parnham, Ulrike Köhl, Susanne Schiffmann
Frontiers in Immunology.2020;[Epub]     CrossRef
Prediction of Potential Associations Between miRNAs and Diseases Based on Matrix Decomposition
Pengcheng Sun, Shuyan Yang, Ye Cao, Rongjie Cheng, Shiyu Han
Frontiers in Genetics.2020;[Epub]     CrossRef